Instructions for Authors

Iranian Blood Transfusion Organization Research Center (IBTO-RC) and the Scientific Association of Blood Transfusion publish this journal quarterly in collaboration with  different scientific associations including Anesthesiology and Emergency Care, Pediatric Hematology-Oncology, Hematology-Oncology, Virology, Iranian Pathologists, Iranian Society of Surgeons, and Bone Marrow Transplantation Research Center. The objectives of this scientific quarterly journal are to promote and disseminate investigations pertinent to the domains of blood donors recruitment and training, screening methods, the appropriate use of blood and blood components, and modern technologies in the field of transfusion sciences and transfusion medicine, all aiming at promoting blood safety.
This journal is indexed by a few international databanks (IMEMR, EBSCO, CINAHL, Index Copernicus) and a few local Iranian databanks (Magiran, SID, Iranmedex, ISC). According to the latest evaluation in 2011 made by Iranian Medical Journals Commission, the Blood Research Quarterly obtained the 1^st scientific ranking. Researchers and students can access the published articles through the website address of www.bloodjournal.ir. Interested authors to submit their articles to the journal office should use the website and observe all the instructions. They should first register in the website and enter the submission page by their username and password and follow the steps below:

1. Visit the journal website
2. Enter "Article Submission" page
3. Add the general details of the article based on the electronic slip (the number of authors, the article topic, the article type, the article language)
4. Register the article data based on the electronic slip

• The topic in English
• English abstract
• English keywords
• Farsi topic
• Farsi abstract
• Farsi keywords
• Authors details
• Manuscript main file; prepared according to the requirements that would be stated in "manuscript submission and technical requirements".
• Manuscript file without authors names and affiliations (optional)

5. An email will be automatically forwarded to your email address that acknowledges the receipt of your main article. Notice that this does not imply the acceptance of the article.
6. The corresponding author by referring to their logged-in access page on the journal website can be informed on the latest status of their article and its acceptance or rejection.

1. Articles will be published in The Scientific Journal of Iranian Blood Transfusion Organization Research Center under four categories:

1. Research article

2. Review article

3. Case report

1. All articles should be in Farsi language fully in accordance to Farsi grammar and writing patterns. Farsi terms should replace foreign language words. If there is no Farsi equivalent in common use, phonetic writing should apply.
2. Manuscripts are received with the explicit understanding that they have not previously been published elsewhere nor are they under simultaneous consideration by any other publisher; this point should be confirmed by the corresponding author in writing. Exceptions to this rule are:

1. 2. The abstract published in international non-local journals in non-Farsi language. In such cases, it is preferable to demand the permission of the publisher with 40% difference of the scientific article contents from the firstly published copy.

3. Name, family name, title, and role of all authors should be written in order and all authors should be aware of its submission and publication. The name of the corresponding author should be notified. The corresponding author is legally include the names and family names of co-authors.
4. The article writing in the present journal lies upon the writing principles of biomedical articles approved of and issued by International Committee of Medical Journal Editors in Vancouver.
5. The patient identity information should not be reflected in writings, images, and genealogies unless they are considered essential for scientific purposes and the patient (or their parents or guardian) sign the written informed consent permitting the publication.
6. All authors should observe all codes of ethics in clinical and animal studies and the submitted article should bear the approval of the ethics committee issued by the authorized sources and the ethics code should be referred to at the end of the article at “ethical considerations” section. All articles derived from clinical trials and interventional studies over human subjects should be registered in a valid clinical trial site with its registry number to appear at the materials and methods section. 
7. All names used as abbreviations for the first time in the manuscript, tables, and the like should be added in parenthesis in full.
8. In case, figures prepared by SPSS or Excel are copy pasted in the Word program, their main sources should be also provided so that the required changes could be made.
9. The journal is entitled the right to accept or reject or modify the article and if deemed appropriate to inform the author(s) on the revisions.
10.  The corresponding author should declare any competing interests or loyalties that can be implied as conflicts of interest. At the end of the article, any conflicts should be asserted.
11.  At the end of the initial submission process, the articles are forwarded to editorial board members. If the article meets the journal requirements in contents and structure, it is further processed and sent to referees. After the referee decisions are obtained, the article is put in the publication waiting list and the corresponding author is informed on it. After the article is published, all relevant documents would not be kept in the journal office more than six months.
12. The author(s) are held responsible for the accuracy of contents, ideas and opinions posed in the article and the intellectual rights of the author(s) are reserved.  
13. To enhance the local research projects, it is imperative to give reference to locally published articles pertinent to newly submitted articles.

1. The title should be brief and to the point including the full title and reflecting the content of the study; it should consist of full names of authors and their highest academic degrees (written in MD, PhD, BS, MS forms), field of study, faculty, university, city, country and full postal address with their email and fax numbers. The running title (maximum four words) should be written above the pages.
2. Abstract

1. Abstract of the original research should comprise of at least 150 to 250 words including background and objectives, materials and methods, statistical analysis, results, discussion, and conclusions. There should be an English version of the abstract. Farsi and English abstracts should appear as Farsi translation equivalence; the title and author names and affiliations should be in English as well. Key words ranging from 3-6 items should be written according to MeSH list of Index Medicus (http://www.nlm.nih.gov/mesh/MBrowser.html).
2. Abstracts of review article should be less than 300 words and preferably developed as instructed below:

3. Case report abstract should not exceed 125 words and should contain the reasons for the research and the research aim together with a brief on clinical findings, important lab abnormalities, the treatment regimen and the outcome; the conclusions in the abstract summarizes findings, the main discoveries, and the reasons for the case uniqueness. Just the use of 3 to 10 keywords according to MeSH is allowed.
4. The abstract of the short article should be less than 200 words and contain background and aim, materials and methods, findings, conclusions; just the use of 3 to 10 keywords according to MeSH is allowed.

3. Introduction

4. Materials and Methods

5. Ethical policy

6. Statistical principles

7. Findings

8. Discussion

9. Conclusions

10. Acknowledgements

11. References

12. Symbols and abbreviations

13. Manuscripts can also be submitted online at www.bloodjournal.ir.

Email: sjibtoibto.ir             Tel/Fax: +98-21-88601599